It is a financial services private limited company based in Mumbai, Maharashtra, India, established in 1973.
1973 | Mumbai, Maharashtra, India | ActiveVilco Pharma Private Limited, a active private limited company, was established on 26 December 1973 in Mumbai, Maharashtra, India. Engaging in real estate financing within the real estate sector, it holds CIN: U24239MH1973PTC017094. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.31 M.
It upholds a compliant status. Its leadership includes Pritul Gajendra Sanghavi (Additional Director), Milan Rasiklal Mehta (Director). Past directors included Jaysukh Narshi Maru, Bimal Kantilal Haria, Kantilal Lakhamshi Maru. It holds ₹9.31 Cr open charges and ₹46.70 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Haria Center 8Subhash Road Vile Parle East, Mumbai, Maharashtra, 400057.
U24239MH1973PTC017094
017094
26 December 1973
₹2.50 M
₹0.31 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Vilco Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pritul Gajendra Sanghavi | Additional Director | 10 Mar 2021 | Current |
| Milan Rasiklal Mehta | Director | 01 Nov 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Mar 2021 | Past |
| Pramod Abcsdd | Director | 01 Nov 2016 | Past |
| Pramod Abcsdd | Director | 01 Nov 2016 | Past |
| Pramod Abcsdd | Director | 01 Nov 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vilco Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 75.53% decrease. The company also saw a slight improvement in profitability, with a 4.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Vilco Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹93,146,000.00
₹466,978,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2024 | Axis Bank Limited | ₹4.00 Cr | Open |
| 11 Jan 2021 | Axis Bank Limited | ₹4.99 Cr | Open |
| 24 Jan 2001 | The North Kanara Gsb Co-Op Bank Ltd. | ₹1.98 M | Open |
| 22 Sep 1978 | State Bank Of India | ₹0.57 M | Open |
| 22 Sep 1978 | State Bank Of India | ₹0.57 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vilco Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vilco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vilco Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vilco Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Axis Bank Limited amounted to Rs. 40.00 M with Charge ID 100972426 was registered on 26 Jul 2024. was documented.
The activity Vilco Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Pritul Gajendra Sanghavi was appointed as a Additional Director was appointed as a Additional Director on 10 Mar 2021 & has been associated with this company since 4 years 10 months . was documented.
A charge with Axis Bank Limited amounted to Rs. 49.90 M with Charge ID 100404594 was registered on 11 Jan 2021. was recorded as a recent event.
A charge registered on 08 Feb 2016 via Charge ID 10621229 with Hdfc Bank Limited was fully satisfied on 05 Jan 2021. was recorded as a recent event.
The CIN of Vilco Pharma Private Limited is U24239MH1973PTC017094.
Vilco Pharma Private Limited is headquartered at Haria Center 8Subhash Road Vile Parle East, Mumbai, Maharashtra, 400057.
Vilco Pharma Private Limited was incorporated on 26 December 1973.
The current directors of Vilco Pharma Private Limited are
The primary industry of Vilco Pharma Private Limited is Real Estate.
Vilco Pharma Private Limited is unlisted.
The authorized capital of Vilco Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹0.31 M.
The compliance status of Vilco Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX